Asahi Kasei Corporate Venture Capital
8
26M
7
0.50
0.12
- Stages of investment
- Areas of investment
Summary
Asahi Kasei Corporate Venture Capital is the famous VC, which was founded in 2008. The venture was found in North America in United States. The main office of represented VC is situated in the Menlo Park.
Among the most popular fund investment industries, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Feldan Therapeutics, Hazel Technologies. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Asahi Kasei Corporate Venture Capital, startups are often financed by Valley Oak Investments, Rhapsody Venture Partners, VentureWell. The meaningful sponsors for the fund in investment in the same round are Valley Oak Investments, Stonebridge Ventures, Serra Ventures. In the next rounds fund is usually obtained by National Institutes of Health.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 0
- Rounds per year
- 0.50
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (5)
- Health Care (3)
- Industrial Supplies and Parts (2)
- AgTech (2)
- Agriculture (2) Show 10 more
- Investments by region
-
- United States (6)
- Canada (1)
- China (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 85M
- Group Appearance index
- 1.00
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Swing Therapeutics | 16 Jun 2022 | Biotechnology, Therapeutics | Early Stage Venture | 10M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.